The tweet was deleted by the author.
But we saved everything 🙂.
Emergent Biosolutions announced a new partnership with Asimov to accelerate the development of innovative antibody candidates aimed at strengthening preparedness against evolving biological threats.
The collaboration is focused on driving progress in novel antibody research to enhance protection measures and support public health defense initiatives.
View post on X Loading...
Emergent Biosolutions recently secured up to a $22.3 million contract modification with the U.S. Department of War to supply medical products, according to a previous company announcement. The contract is part of the firm's ongoing efforts to support government preparedness initiatives. The new partnership with Asimov builds on these activities by advancing antibody research aimed at countering biological risks.